Ikarian Capital’s Milestone Pharmaceuticals MIST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-466,030
| Closed | -$1.1M | – | 151 |
|
|
2024
Q4 | $1.1M | Buy |
466,030
+11
| +0% | +$26 | 0.15% | 64 |
|
|
2024
Q3 | $708K | Hold |
466,019
| – | – | 0.1% | 68 |
|
|
2024
Q2 | $620K | Hold |
466,019
| – | – | 0.11% | 64 |
|
|
2024
Q1 | $834K | Buy |
466,019
+3,191
| +0.7% | +$5.71K | 0.09% | 60 |
|
|
2023
Q4 | $773K | Hold |
462,828
| – | – | 0.07% | 56 |
|
|
2023
Q3 | $1.43M | Buy |
462,828
+2,412
| +0.5% | +$7.48K | 0.17% | 39 |
|
|
2023
Q2 | $1.31M | Hold |
460,416
| – | – | 0.21% | 43 |
|
|
2023
Q1 | $1.81M | Hold |
460,416
| – | – | 0.41% | 39 |
|
|
2022
Q4 | $1.82M | Sell |
460,416
-395,200
| -46% | -$1.56M | 0.44% | 31 |
|
|
2022
Q3 | $7.86M | Sell |
855,616
-523,806
| -38% | -$4.81M | 1.57% | 7 |
|
|
2022
Q2 | $8.19M | Sell |
1,379,422
-549,330
| -28% | -$3.26M | 1.49% | 12 |
|
|
2022
Q1 | $12.4M | Buy |
1,928,752
+178,709
| +10% | +$1.15M | 1.63% | 4 |
|
|
2021
Q4 | $11.5M | Hold |
1,750,043
| – | – | 1.71% | 7 |
|
|
2021
Q3 | $9.99M | Sell |
1,750,043
-230,357
| -12% | -$1.32M | 0.7% | 10 |
|
|
2021
Q2 | $10.9M | Buy |
1,980,400
+143,855
| +8% | +$791K | 0.88% | 11 |
|
|
2021
Q1 | $10.6M | Hold |
1,836,545
| – | – | 0.36% | 14 |
|
|
2020
Q4 | $12.3M | Buy |
1,836,545
+93,000
| +5% | +$623K | 0.54% | 12 |
|
|
2020
Q3 | $12.8M | Buy |
+1,743,545
| New | +$12.8M | 0.92% | 4 |
|